FDA Approved: ASPARLAS — Supplemental Application (Servier Pharmaceuticals LLC)

View source ↗

Summary

FDA issued a supplemental approval for ASPARLAS (calaspargase pegol) from Servier Pharmaceuticals LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Drugs mentioned

• Asparlas (calaspargase pegol)

Snippet

SUPPL AP for ASPARLAS (CALASPARGASE PEGOL)